All Stories

  1. Cancer-associated and non-neoplastic fibrosis: Comparative mechanisms and emerging antifibrotic strategies
  2. Computational tools for personalizing treatment of acute respiratory failure, from machine learning to digital twins: a narrative review
  3. Efficacy and tolerability of generic pirfenidone after switch from Esbriet® in idiopathic pulmonary fibrosis: a real-world observational study
  4. Efficacy and Tolerability of Generic Pirfenidone After Switch from Esbriet® in Idiopathic Pulmonary Fibrosis: A Real-World Observational Study
  5. Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection
  6. Alpha-1 Antitrypsin Deficiency Beyond COPD and Emphysema: A Narrative Review
  7. High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial
  8. In-hospital testing of NIVPredict - an AI tool for early prediction of non-invasive ventilation outcome in acute respiratory failure
  9. Physiopathology of Exacerbation of Chronic Obstructive Pulmonary Disease
  10. Multiperspective ultrasonography in COPD exacerbations: insights into inspiratory muscle recruitment and clinical outcomes. Author’s reply
  11. The forgotten airway: central airway pathology in the ICU
  12. Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms
  13. Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets
  14. Digital twins of acute hypoxemic respiratory failure and sepsis patients suggest potential benefits of bi-level high flow nasal cannula therapy
  15. Stent and Resection Anastomosis in Patients with Complex Tracheal Stenosis: The Stars Retrospective Multicenter Trial
  16. Ultrasound-based evaluation of inspiratory muscle effort in patients with type 2 respiratory failure secondary to exacerbation of chronic obstructive pulmonary disease
  17. Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress
  18. Evaluating the effect of heart and respiratory rate measurement errors on the ability to predict the outcome of high flow nasal cannula therapy: a multi-centre study
  19. Predicting and Treating Pulmonary Fibrosis with Proteomic Biomarker Investigations
  20. Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial
  21. Assessing inspiratory drive and effort in critically ill patients at the bedside
  22. Early prediction of non-invasive ventilation outcome using the TabPFN machine learning model: a multi-centre validation study
  23. Refining the predictive value of nasal pressure swing in acute hypoxemic respiratory failure management. Author's reply
  24. The use of the MoCA in cognitive impairment for older patients with Chronic Obstructive Pulmonary disease: A preliminary study
  25. Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents
  26. Digital twins suggest a mechanistic basis for differing responses to increased flow rates during high-flow nasal cannula therapy
  27. Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure
  28. Role of COVID‐19 in the Progression of Scleroderma Interstitial Lung Disease and New Onset Pulmonary Hypertension: A Challenging Case Report
  29. The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options—A Review
  30. Machine learning models compared with current clinical indices to predict the outcome of high flow nasal cannula therapy in acute hypoxemic respiratory failure
  31. Respiratory Muscle Dysfunction and Associated Risk Factors Following COVID-19-Related Hospitalisation
  32. Airway pressures generated by high flow nasal cannula in patients with acute hypoxemic respiratory failure: a computational study
  33. Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences
  34. Rehabilitation and physiotherapists in the critical care medicine
  35. Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study
  36. Quantitative CT-analysis of over aerated lung tissue and correlation with fibrosis extent in patients with idiopathic pulmonary fibrosis
  37. Bronchiectasis as long-term complication of acute fire smoke inhalation?
  38. Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing
  39. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study protocol for a multicentre European observational study
  40. Expression of HOXB7 in the Lung of Patients with Idiopathic Pulmonary Fibrosis: A Proof-of-Concept Study
  41. Stress–strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  42. Digital Twins of Acute Hypoxemic Respiratory Failure Patients Suggest a Mechanistic Basis for Success and Failure of Noninvasive Ventilation
  43. Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
  44. Integrated endoscopic treatment of primitive unresectable tracheal tumor: the INTACT retrospective cohort study
  45. When sarcoidosis hits down: a case of prostatic sarcoidosis
  46. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a multicentre European observational study
  47. Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?
  48. Impact of Frailty on Symptom Burden in Chronic Obstructive Pulmonary Disease
  49. Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis
  50. Efficacy of Respiratory Muscle Training in the Immediate Postoperative Period of Cardiac Surgery: A Systematic Review and Meta-Analysis
  51. Home noninvasive ventilation in severe COPD: in whom does it work and how?
  52. Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate orders
  53. COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
  54. Disease burden of people with uncontrolled severe asthma with and without biomarkers of inflammation
  55. Inspiratory Effort and Respiratory Mechanics in Patients with Acute Exacerbation of Idiopathic Pulmonary fibrosis: A Preliminary Matched Control Study
  56. Stress-strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  57. Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
  58. Physiological effects of lung-protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study
  59. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
  60. Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
  61. Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis
  62. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
  63. Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease
  64. Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma
  65. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes
  66. Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
  67. Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia
  68. One‐year clinical experience on the use of Nintedanib in systemic sclerosis
  69. Case report: Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula
  70. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
  71. Accuracy of Nasal Pressure Swing to Predict Failure of High-Flow Nasal Oxygen in Patients with Acute Hypoxemic Respiratory Failure
  72. Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
  73. COPD: Providing the right treatment for the right patient at the right time
  74. Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
  75. Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft
  76. Biological effects of COVID-19 on lung cancer: Can we drive our decisions
  77. Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial
  78. Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study
  79. The burden of disease in people with mild asthma
  80. Treatable traits in the NOVELTY study
  81. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
  82. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
  83. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
  84. Persistent asthma hospitalisations and deaths require a national asthma prevention plan
  85. Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study
  86. Risk Factors for Pulmonary Air Leak and Clinical Prognosis in Patients With COVID-19 Related Acute Respiratory Failure: A Retrospective Matched Control Study
  87. Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure
  88. Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
  89. Rehabilitation of Difficult-to-Wean, Tracheostomized Patients Admitted to Specialized Unit: Retrospective Analyses over 10-Years
  90. Stenting versus balloon dilatation in patients with tracheal benign stenosis: The STROBE trial
  91. Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults
  92. Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study
  93. Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  94. Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
  95. First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
  96. Extensive Tracheal Injuries: A Reasoned Multistep Approach to Guarantee Mechanical Ventilatory Support Developed During the COVID‐19 Pandemic
  97. Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study
  98. In memoriam Claudio F. Donner
  99. Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
  100. Urgent need of novel biomarkers of acute dyspnea
  101. Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
  102. Acute severe asthma: management and treatment
  103. Combined approach to define the clinical impact and decision making in asthmatics
  104. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
  105. Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  106. ERS/EAACI statement on adherence to international adult asthma guidelines
  107. Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study
  108. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
  109. Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
  110. Changes in Clinical Characteristics and Outcomes of Patients Admitted to Inpatient Cardiac Rehabilitation
  111. Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
  112. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
  113. Rehabilitative practice in Europe: Roles and competencies of physiotherapists. Are we learning something new from COVID-19 pandemic?
  114. Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
  115. Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
  116. Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
  117. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
  118. Never Give Up: Lesson learned from a severe COVID-19 patient
  119. Defining Modern Pulmonary Rehabilitation. An Official American Thoracic Society Workshop Report
  120. COVID-Guide: una app per il triage e l’autovalutazione della covid-19
  121. Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.
  122. Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario
  123. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
  124. Looking Ahead in Pulmonary Rehabilitation
  125. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
  126. Reply to Spinelli et al. and to Jha: Continued Vigorous Inspiratory Effort as a Predictor of Noninvasive Ventilation Failure
  127. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial
  128. Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study
  129. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
  130. Unusual effectiveness of systemic steroids in Whipple disease
  131. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
  132. Echoendoscopic appearance of mediastinal metastasis from papillary renal carcinoma
  133. Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE)
  134. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)
  135. Reply to Tuffet et al. and to Michard and Shelley
  136. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies
  137. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study
  138. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia
  139. Tocilizumab in patients with severe COVID-19: a retrospective cohort study
  140. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
  141. Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease
  142. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
  143. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a st...
  144. Italian suggestions for pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process
  145. COVID-19 and pulmonary rehabilitation: preparing for phase three
  146. Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
  147. An Italian sacrifice to the COVID-19 epidemic
  148. High-Flow Oxygen Therapy During Exercise Training in Patients With Chronic Obstructive Pulmonary Disease and Chronic Hypoxemia: A Multicenter Randomized Controlled Trial
  149. Handling and Processing of Blood Specimens from Patients with COVID‐19 for Safe Studies on Cell Phenotype and Cytokine Storm
  150. Obstructive sleep apnea and blood pressure in young hypertensives: does it matter?
  151. Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball”
  152. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
  153. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper
  154. Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients
  155. Vessel Diseases
  156. A case of dyspnea: respiratory failure due to pulmonary arteriovenous malformation
  157. Prognostication by concomitant organ failure in mechanically ventilated patients in ICU: Important issue to face with
  158. Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment
  159. Respiratory Mechanics and Diaphragmatic Dysfunction in COPD Patients Who Failed Non-Invasive Mechanical Ventilation
  160. Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting
  161. Gender differences in chronic obstructive pulmonary disease: Can be the DRG-based diagnosis the best way for a right analysis?
  162. Atypical diagnosis for typical lung carcinoid
  163. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD
  164. Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis
  165. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
  166. Janus-faced amiodarone-induced pneumopathy
  167. Clinical differences in sarcoidosis patients with and without lymphoma
  168. Do Not Forget to Assess the Muscle Integrity in Patients With COPD
  169. Introduction of the harmonised respiratory physiotherapy curriculum
  170. A guide for respiratory physiotherapy postgraduate education: presentation of the harmonised curriculum
  171. Manual Massage Therapy for Patients with COPD: A Scoping Review
  172. Exercise and Sports Pulmonology
  173. Cardiac disease
  174. Pulmonary Rehabilitation
  175. Assessment of Symptoms in Patients with COPD: Strengths and Limitations of Clinical Scores
  176. LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
  177. Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure
  178. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure
  179. An uncommon cause of hemoptysis: aortobronchial fistula
  180. Tai Chi Recreational Exercise Is Not Rehabilitation
  181. Evaluation of health-related quality of life in pulmonary diseases
  182. The encaged lung: rapidly progressive idiopathic pleurisy
  183. Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma
  184. Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
  185. Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation
  186. Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
  187. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
  188. Update in rehabilitation of respiratory patients
  189. Looking for a chronic care model in COPD patients
  190. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
  191. Incidence, Etiology, and Clinicopathologic Features of Endobronchial Benign Lesions
  192. Conventional Programs: Settings, Cost, Staffing, and Maintenance
  193. Conclusions: Perspectives in Pulmonary Rehabilitation
  194. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
  195. Chronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly
  196. Update on physiotherapy applicable to patients in intensive care. Practical aspects and perspectives
  197. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects
  198. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
  199. Integrating the care of the complex COPD patient
  200. GOLD 2017 recommendations for COPD patients: toward a more personalized approach
  201. COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply
  202. An uncommon cause of pneumonia: The golden diagnosis
  203. Prevalence and outcomes of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of COPD: A pilot study
  204. What is the origin of dyspnoea in smokers without airway disease?
  205. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
  206. Management and Therapy for Pulmonary Hypertension: 2016 Update
  207. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis
  208. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease
  209. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers
  210. Activity and analysis of costs in a dedicated weaning centre
  211. Learning impact of education during Pulmonary Rehabilitation program. An observational short-term cohort study
  212. Organization of a Weaning Unit
  213. La ventilazione non invasiva in Medicina Interna
  214. Advanced COPD patients under Home Mechanical Ventilation and/or Long Term Oxygen Therapy: Italian Healthcare Costs
  215. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation
  216. Response to pulmonary rehabilitation: toward personalised programmes?
  217. Chronic critical illness: the price of survival
  218. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – Part 3
  219. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2
  220. 8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1
  221. Comorbidities in elderly smokers with COPD or CHF
  222. Impaired function in the complex patient with COPD: a matter to be considered
  223. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  224. Clinical highlights: messages from Munich
  225. Development of a syllabus for postgraduate respiratory physiotherapy education: the Respiratory Physiotherapy HERMES project
  226. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
  227. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  228. A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes
  229. Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and management: Figure 1–
  230. A conceptual framework for reporting experience of physical activity in COPD
  231. Pulmonary rehabilitation in Italy: professional barriers to overcome
  232. An official European Respiratory Society statement on physical activity in COPD
  233. A core syllabus for post-graduate training in respiratory physiotherapy
  234. In COPD patients on prolonged mechanical ventilation heart rate variability during the T-piece trial is better after pressure support plus PEEP: A pilot physiological study
  235. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial
  236. Impaired arm activity in COPD: a questionable goal for rehabilitation
  237. Clinical highlights from the 2013 ERS Congress in Barcelona
  238. Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease
  239. Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
  240. Multimorbidity in Elderly Patients with Chronic Obstructive Pulmonary Disease: Stop Smoking! Go Exercise?
  241. Differences in content and organisational aspects of pulmonary rehabilitation programmes
  242. Fat-Free Mass Depletion Is Associated With Poor Exercise Capacity Irrespective of Dynamic Hyperinflation in COPD Patients
  243. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
  244. Chronic Obstructive Pulmonary Disease (COPD) and Metabolic Disorders in Elderly Smokers
  245. Towards health benefits in chronic respiratory diseases: pulmonary rehabilitation
  246. Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease
  247. Noninvasive mechanical ventilation with high pressure strategy remains a “double edged sword”?
  248. Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD
  249. Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity
  250. Chronic Obstructive Pulmonary Disease Is Just One Component of the Complex Multimorbidities in Patients with COPD
  251. Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease
  252. Predicting Walking-Induced Oxygen Desaturations in COPD Patients: A Statistical Model
  253. Feasibility and Effectiveness of an Educational Program in Italian COPD Patients Undergoing Rehabilitation
  254. Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals
  255. Effect of Rehabilitative Exercise Training on Peripheral Muscle Remodelling in Patients with COPD: Targeting Beyond the Lungs
  256. Pulmonary Rehabilitation Improves Cardiovascular Response to Exercise in COPD
  257. Respiratory Muscle Training in Patients Recovering Recent Open Cardiothoracic Surgery: A Randomized-Controlled Trial
  258. Selected clinical highlights from the 2012 ERS congress in Vienna: Table 1–
  259. Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial
  260. Pulmonary rehabilitation following radical chemo-radiation in locally advanced non surgical NSCLC: Preliminary evidences
  261. Clinical highlights from the 2011 ERS Congress in Amsterdam
  262. Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients
  263. Rehabilitation, weaning and physical therapy strategies in chronic critically ill patients
  264. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients
  265. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation
  266. Co-morbidities in chronic respiratory patients: limitations or opportunities for caring?
  267. COPD and the metabolic syndrome: an intriguing association
  268. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients
  269. Energy Expenditure at Rest and during Walking in Patients with Chronic Respiratory Failure: A Prospective Two-Phase Case-Control Study
  270. Rehabilitation in COPD patients: evergreen in pneumology and beyond
  271. Safety and Efficacy of Short-Term Intrapulmonary Percussive Ventilation in Patients With Bronchiectasis
  272. Selected clinical highlights from the 2010 ERS Congress in Barcelona
  273. Complessità del paziente con insufficienza respiratoria cronica associata a BPCO
  274. Functional Recovery Following Physical Training in Tracheotomized and Chronically Ventilated Patients
  275. Non-invasive ventilation in elderly patients with acute hypercapnic respiratory failure: a randomised controlled trial
  276. Non-invasive Ventilation and Weaning: Principles and Practice
  277. Early Rehabilitation
  278. Efficacy of standard rehabilitation in COPD outpatients with comorbidities
  279. Measures of dyspnea in pulmonary rehabilitation
  280. Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Soci...
  281. Erratum to: Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  282. Effects of early inpatient rehabilitation after acute exacerbation of COPD
  283. Patients’ characterization, hospital course and clinical outcomes in five Italian respiratory intensive care units
  284. "ERS/ESTS CLINICAL GUIDELINES ON FITNESS FOR RADICAL THERAPY IN LUNG CANCER PATIENTS (SURGERY AND CHEMO-RADIOTHERAPY)". A. BRUNELLI, A. CHARLOUX, C.T. BOLLIGER, G. ROCCO, J-P. SCULIER, G. VARELA, M. LICKER, M.K. FERGUSON, C. FAIVRE-FINN, R.M. HUBER, E....
  285. Last 3 months of life in home-ventilated patients: the family perception
  286. Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  287. Effects of Unsupported Upper Extremity Exercise Training in Patients With COPD
  288. Long-term Weight Loss and Maintenance in Morbidly Obese Individuals with Obstructive Sleep Apnea
  289. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer
  290. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
  291. Short-term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review
  292. Use of functional independence measure in rehabilitation of inpatients with respiratory failure
  293. Exercise Capacity as a Pulmonary Rehabilitation Outcome
  294. Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial
  295. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects
  296. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
  297. Predictors of 6-Month Mortality in Elderly Patients with Mild Chronic Obstructive Pulmonary Disease Discharged from a Medical Ward After Acute Nonacidotic Exacerbation
  298. Home Non-Invasive Mechanical Ventilation and Long-Term Oxygen Therapy in Stable Hypercapnic Chronic Obstructive Pulmonary Disease Patients: Comparison of Costs
  299. Indications and Physiological Basis of Rehabilitation in the ICU
  300. Nutrition in ICU
  301. Nonpharmacological treatment and relief of symptoms in COPD
  302. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study
  303. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer
  304. Effects of a Walking Aid in COPD Patients Receiving Oxygen Therapy
  305. Respiratory muscles training in COPD patients
  306. Intrapulmonary percussive ventilation in tracheostomized patients: a randomized controlled trial
  307. Maximal inspiratory and expiratory pressure measurement in tracheotomised patients
  308. Repeated Pulmonary Rehabilitation in Severe and Disabled COPD Patients
  309. Inspiratory Muscle Training: A Way to Breathe More Easily
  310. EFFECTIVENESS OF A REHABILITATION PROGRAM IN MORBIDLY OBESE SUBJECTS WITH SLEEP DISTURBANCIES
  311. Supported Arm Training in Patients Recently Weaned From Mechanical Ventilation
  312. Early physiotherapy in the respiratory intensive care unit
  313. Length and Clinical Effectiveness of Pulmonary Rehabilitation in Outpatients With Chronic Airway Obstruction
  314. Inpatient pulmonary rehabilitation: does it make sense?
  315. Assessment of Physiologic Variables and Subjective Comfort Under Different Levels of Pressure Support Ventilation
  316. Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation
  317. Long-term mechanical ventilation and nutrition
  318. Occupational Therapy and Pulmonary Rehabilitation of Disabled COPD Patients
  319. Effects of Respiratory Therapist-Directed Protocol on Prescription and Outcomes of Pulmonary Rehabilitation in COPD Inpatients
  320. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
  321. Exhaled nitric oxide and exercise tolerance in severe COPD patients
  322. In-Hospital Short-term Training Program for Patients With Chronic Airway Obstruction
  323. Physiological Response to Pressure Support Ventilation Delivered before and after Extubation in Patients Not Capable of Totally Spontaneous Autonomous Breathing
  324. Erratum
  325. Comparison of Two Methods for Weaning Patients with Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation for More Than 15 Days
  326. Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease
  327. Exhaled nitric oxide in patients with PiZZ Phenotype-related α 1-anti-trypsin deficiency
  328. The Appropriate Setting of Noninvasive Pressure Support Ventilation in Stable COPD Patients
  329. Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale
  330. Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure
  331. Preliminary results on nursing workload in a dedicated weaning center
  332. Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies
  333. Exhaled Nitric Oxide and Exercise in Stable COPD Patients
  334. Physiological effects of posture on mask ventilation in awake stable chronic hypercapnic COPD patients
  335. BIOEQUIVALENCE OF LEVOTHYROXINE TABLETS ADMINISTERED TO A TARGET POPULATION IN STEADY STATE
  336. DETECTION OF NITRIC OXIDE IN EXHALED AIR OF DIFFERENT ANIMAL SPECIES USING A CLINICAL CHEMILUMINESCENCE ANALYSER
  337. Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute excerbation
  338. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation
  339. Silver/silver chloride electrodes for measurement of potential difference in human bronchi
  340. Two Germans
  341. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency
  342. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis
  343. Breathing Pattern and Respiratory Mechanics in Chronically Tracheostomized Patients with Chronic Obstructive Pulmonary Disease Breathing Spontaneously through a Hygroscopic Condenser Humidifier
  344. Non-Invasive Haemodynamic Effects of Two Nasal Positive Pressure Ventilation Modalities in Stable Chronic Obstructive Lung Disease Patients
  345. Evaluation in pulmonary rehabilitation
  346. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia
  347. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation
  348. Non-invasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure: short-and long-term prognosis
  349. Does the Supine Position Worsen Respiratory Function in Elderly Subjects?
  350. Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases
  351. Transcutaneous Partial Oxygen Tension and Lung Mechanics During Methacholine Inhaled Challenge
  352. Respiratory muscle function and exercise capacity in multiple sclerosis
  353. Ceftizoxime in Lower Respiratory Tract Infection